Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-089-3 | CAS number: 1300-71-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 March 2004 to 11 April 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- yes
- Principles of method if other than guideline:
- Deviations: The dosage, postdosage and scheduled sacrifice periods were each extended for an additional 3 days. 30 rats were received at the testing facility rather than the 20 rats stated in the protocol. Rat 5389 in the 550 mg/kg/day dosage group was given 3 h and 4 h observations at 4 h 39 minsand 4 h 46 mins, respectively. These deviations are not considered to adversely affect the study integrity.
- GLP compliance:
- yes
- Remarks:
- Quality assurance statement only.
- Test type:
- up-and-down procedure
- Limit test:
- no
Test material
- Reference substance name:
- Ethyl phenols
- IUPAC Name:
- Ethyl phenols
- Details on test material:
- - Name of test material (as cited in study report): Ethyl phenols
- Substance type: Phenol
- Physical state: Liquid
- Analytical purity: 98.81%
- Impurities (identity and concentrations): Not stated
- Composition of test material, percentage of components: Not stated
- Isomers composition: Not applicable
- Purity test date: Not stated
- Lot/batch No.: 13JAN2004
- Expiration date of the lot/batch: Not stated
- Stability under test conditions: Not stated
- Storage condition of test material: Closed container at room temperature and protected from light
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD)IGS BR VAF/Plus
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Portage, Michigan, USA
- Age at study initiation: 63 days (at arrival)
- Weight at study initiation: 197 - 223 g (the day after arrival)
- Fasting period before study: Fasted on the night before the dosage administration, with feed returned to the animals following the 4 h clinical observation.
- Housing: Individually housed in stainless-steel wire-bottomed cages.
- Diet (e.g. ad libitum): Certified Rodent Diet #5002 (PMI Nutrition International, Inc., St. Louis, Missouri, USA).
- Water (e.g. ad libitum): Local water, passed through a reverse osmosis membrane, available ad libitum, via individual water bottles. Chlorine was added to the processed water as a bacteriostat.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 64 - 79°F (18 - 26°C)
- Humidity (%): 30 - 70%
- Air changes (per hr): Positive airflow, minimum of 10 changes per hour of HEPA filtered air.
- Photoperiod (hrs dark / hrs light): 12 h dark / 12 h light
IN-LIFE DATES: From: 15 March 2004 To: 11 April 2004
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 35 mg/mL vehicle, 110 mg/mL vehicle and 350 mg/mL vehicle
- Amount of vehicle (if gavage): 5 mL/kg
- Justification for choice of vehicle: Not stated, guideline vehicle substance.
- Lot/batch no. (if required): 062K0006
- Purity: Not stated - Doses:
- 175, 550 and 1750 mg/kg/day
- No. of animals per sex per dose:
- All females, 1 rat for 175 mg/kg/day, 4 rats for 550 mg/kg/day, 4 rats for 1750 mg/kg/day,
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Pre-dose, at least once in the 30 mins after dosage, approx. hourly intervals for the first 4 h and then daily thereafter for observations. Body weights were recorded weekly during acclimation, daily during the dosing and observation period and at sacrifice.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, feed consumption
Results and discussion
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 980.62 other: mg/kg
- Remarks on result:
- other: Calculated from log10 values.
- Sex:
- male/female
- Dose descriptor:
- other: NOEL
- Effect level:
- ca. 175 mg/kg bw
- Based on:
- other: Adverse clinical signs at 550 mg/kg bw
- Mortality:
- 3 rats died in the 1750 mg/kg dose group from treatment related effects.
- Clinical signs:
- other: Clinical observations which were determined to be dose related included: lacrimation, excess salivation and urine stained fur in both the 550 and 1750 mg/kg dose groups. Decreased motor activity, twitches, prostrate, ptosis, limited use of hindlimbs, lost
- Gross pathology:
- Necropsy confirmed the clinical observations. No gross lesions were found.
- Other findings:
- Feed consumption values, both absolute (g/day) and relative (g/kg/day) showed a dose dependent reduction in the day after dosing in the 550 and 1750 mg/kg dose groups. This trend continued until day 5 post dosing, after which the values remaind comparative to the 175 mg/kg dosed animal.
Any other information on results incl. tables
Three rats in the 1750 mg/kg/day dose group were found dead during the study. Eight of the nine test animals showed dose related effects. There were no deaths in the 175 and 550 mg/kg/day dose groups. Clinical observations which were determined to be dose related included: lacrimation, excess salivation and urine stained fur in both the 550 and 1750 mg/kg dose groups. Decreased motor activity, twitches, prostrate, ptosis, limited use of hindlimbs, lost proprioceptive positioning, no use of both hind and forelimbs, ataxia, lost righting reflex, tachypnea, impaired righting reflex and scant faeces were observed in the 1750 mg/kg dose group. Necropsy confirmed the clinical observations. No gross lesions were found.
Body weight changes were reduced in the 550 and 1750 mg/kg dose groups compared to the rat in the 175 mg/kg dose group. However, all surviving rats gained weight after dose administration. Feed consumption values, both absolute (g/day) and relative (g/kg/day) showed a dose dependent reduction in the day after dosing in the 550 and 1750 mg/kg dose groups. This trend continued until day 5 post dosing, after which the values remaind comparative to the 175 mg/kg dosed animal.
Table 1: Mortality results of the up and down procedure with ethyl phenols
Step |
Dose (mg/kg) |
Response |
Include |
Log10 dose |
1 |
175 |
O |
No |
- |
2 |
550 |
O |
Yes |
2.740 |
3 |
1750 |
X |
Yes |
3.243 |
4 |
550 |
O |
Yes |
2.740 |
5 |
1750 |
X |
Yes |
3.243 |
6 |
550 |
O |
Yes |
2.740 |
7 |
1750 |
X |
Yes |
3.243 |
8 |
550 |
O |
No |
- |
9 |
1750 |
O |
No |
- |
Total |
17.949 |
O = alive, X = dead
Sum of log10 doses/# of eligible rats: 17.949/6 = 2.9915, antilog of
2.9915 = 980.62 mg/kg = LD50
Table 2: Summary of observations of adverse effects during study
Observation |
175 mg/kg |
550 mg/kg |
1750 mg/kg |
Death |
0 |
0 |
3 |
Lacrimation |
0/0 |
1/1 |
4/4 |
Decreased motor activity |
0/0 |
0/0 |
4/4 |
Twitches |
0/0 |
0/0 |
3/3 |
Prostrate |
0/0 |
0/0 |
3/3 |
Excess salivation |
0/0 |
1/1 |
2/2 |
Ptosis |
0/0 |
0/0 |
2/2 |
Limited use of hindlimbs |
0/0 |
0/0 |
2/2 |
Lost proprioceptive positioning |
0/0 |
0/0 |
2/2 |
No use of both hind and forelimbs |
0/0 |
0/0 |
2/2 |
Ataxia |
0/0 |
0/0 |
2/2 |
Lost righting reflex |
0/0 |
0/0 |
2/2 |
Tachypnea |
0/0 |
0/0 |
2/2 |
Urine stained abdominal fur |
0/0 |
4/2 |
5/1 |
Impaired righting reflex |
0/0 |
0/0 |
1/1 |
Scant faeces |
0/0 |
0/0 |
1/1 |
Clear perinasal substance |
0/0 |
1/1 |
0/0 |
Chromorhinorrhea |
0/0 |
1/1 |
0/0 |
Maximum possible incidence |
14/1 |
56/4 |
17/4 |
Maximum possible incidence = (days x
rats)/number of rats examined per group
N/N = total number of observations/number of rats with observation
Table 3: Summary of body weight data
Rat body weight (g) |
175 mg/kg |
550 mg/kg |
1750 mg/kga |
Day 1 |
203 ± 0.0 |
216.0 ± 14.4 |
225.8 ± 14.9 |
Day 2 |
219.0 ± 0.0 |
223.5 ± 22.7 |
229.0 ± 0.0 |
Day 3 |
216.0 ± 0.0 |
234.2 ± 19.5 |
220.0 ± 0.0 |
Day 4 |
227.0 ± 0.0 |
235.0 ± 19.1 |
234.0 ± 0.0 |
Day 5 |
228.0 ± 0.0 |
240.0 ± 22.4 |
246.0 ± 0.0 |
Day 6 |
233.0 ± 0.0 |
236.2 ± 19.0 |
254.0 ± 0.0 |
Day 7 |
241.0 ± 0.0 |
239.8 ± 21.4 |
258.0 ± 0.0 |
Day 8 |
239.0 ± 0.0 |
243.0 ± 25.1 |
255.0 ± 0.0 |
Day 9 |
241.0 ± 0.0 |
247.5 ± 24.6 |
262.0 ± 0.0 |
Day 10 |
246.0 ± 0.0 |
248.0 ± 22.2 |
262.0 ± 0.0 |
Day 11 |
261.0 ± 0.0 |
250.0 ± 18.8 |
268.0 ± 0.0 |
Day 12 |
254.0 ± 0.0 |
251.0 ± 17.6 |
272.0 ± 0.0 |
Day 13 |
263.0 ± 0.0 |
249.8 ± 24.0 |
279.0 ± 0.0 |
Day 14 |
263.0 ± 0.0 |
252.5 ± 24.0 |
276.0 ± 0.0 |
Mean ± SD
a= Excludes values for rats found dead.
Table 4: Summary of feed consumption data
Feed consumption (g/day) |
175 mg/kg |
550 mg/kg |
1750 mg/kga |
Day 1-2 |
17.0 ± 0.0 |
11.8 ± 3.9 |
1.0 ± 0.0 |
Day 2-3 |
17.0 ± 0.0 |
19.8 ± 3.5 |
1.0 ± 0.0 |
Day 3-4 |
17.0 ± 0.0 |
18.5 ± 5.4 |
12.0 ± 0.0 |
Day 4-5 |
18.0 ± 0.0 |
17.7 ± 1.2 |
17.0 ± 0.0 |
Day 5-6 |
17.0 ± 0.0 |
18.0 ± 5.0 |
20.0 ± 0.0 |
Day 6-7 |
20.0 ± 0.0 |
20.5 ± 1.7 |
24.0 ± 0.0 |
Day 7-8 |
19.0 ± 0.0 |
19.2 ± 5.1 |
22.0 ± 0.0 |
Day 8-9 |
22.0 ± 0.0 |
19.2 ± 4.4 |
22.0 ± 0.0 |
Day 9-10 |
17.0 ± 0.0 |
21.5 ± 1.3 |
26.0 ± 0.0 |
Day 10-11 |
24.0 ± 0.0 |
19.0 ± 1.6 |
24.0 ± 0.0 |
Day 11-12 |
16.0 ± 0.0 |
20.5 ± 3.3 |
24.0 ± 0.0 |
Day 12-13 |
17.0 ± 0.0 |
18.5 ± 3.1 |
25.0 ± 0.0 |
Day 13-14 |
20.0 ± 0.0 |
18.2 ± 3.3 |
21.0 ± 0.0 |
Day 1-14 |
18.5 ± 0.0 |
18.7 ± 2.2 |
18.4 ± 0.0 |
Mean ± SD
a= Excludes values for rats found dead.
Applicant's summary and conclusion
- Executive summary:
Based on this study, the LD50 for ethyl phenols was determined to be 980.62 mg/kg. Mortality occurred in three of the four rats given the highest dose of 1750 mg/kg. Adverse clinical signs were observed at doses of 550 and 1750 mg/kg. A single dose of 175 mg/kg had no observable effect during the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
